A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS
A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS
Recruiting · NCT06849609 · Registry updated 2025-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Early phase 1 | 2025-03-17 | NCT06849609 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hong Chen | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital | Wuhan | China | 25 |